Mito: "es mentira que podemos vacunarnos porque no hay dosis suficientes para todos"
Date:
16/04/2021
Serie: Respuesta de la ciencia a los mitos más escuchados sobre vacunación y #COVID19
Dra. Lucia Alonso. Epidemióloga. Consultora de OPS. Integra el Grupo Asesor Científico Honorario (GACH) de la Presidencia de la República y también el Comité de Emergencia para COVID-19 que asesora al director general de la Organización Mundial de la Salud (OMS), es profesora adjunta en el Departamen...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Health Communication, COVID-19, Mito
Mito: "estas vacunas no nos van a proteger contra la P1"
Date:
16/04/2021
Serie: Respuesta de la ciencia a los mitos más escuchados sobre vacunación y #COVID19
Dra. Lucia Alonso. Epidemióloga. Consultora de OPS. Integra el Grupo Asesor Científico Honorario (GACH) de la Presidencia de la República y también el Comité de Emergencia para COVID-19 que asesora al director general de la Organización Mundial de la Salud (OMS), es profesora adjunta en el Departamen...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/immunology, Immunization Programs/organization & administration, Health Communication, Vaccine Potency, Betacoronavirus/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, DNA, Viral/genetics, Mutation/genetics, COVID-19, Mito, Variante P1
Mito: "la P1 es mucho más agresiva que las otras variantes de COVID-19"
Date:
16/04/2021
Serie: Respuesta de la ciencia a los mitos más escuchados sobre vacunación y #COVID19
Dra. Lucia Alonso. Epidemióloga. Consultora de OPS. Integra el Grupo Asesor Científico Honorario (GACH) de la Presidencia de la República y también el Comité de Emergencia para COVID-19 que asesora al director general de la Organización Mundial de la Salud (OMS), es profesora adjunta en el Departamen...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/immunology, Immunization Programs/organization & administration, Health Communication, Vaccine Potency, Betacoronavirus/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, DNA, Viral/genetics, Mutation/genetics, COVID-19, Mito, Variante P1
Media briefing on COVID-19 and climate change with Dr Tedros and Greta Thunberg - 19/04/2021
Date:
19/04/2021
0:00:34
CL Hello, good day and welcome to... wherever you are listening to us today from [sic]. It's Monday 19th April 2021. My name is Christian Lindmeier and I'm welcoming you to today's global COVID-19 press conference. The press conference today is on COVID updates with a special focus on the linkages between the climate and the COVID-19 crisis and the role of youth in the response ...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Epidemiological Monitoring, Americas/epidemiology, Quarantine/organization & administration, Social Isolation, Ecological Development, Betacoronavirus/immunology, Viral Vaccines/supply & distribution, Access to Essential Medicines and Health Technologies, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Climate Change, Gift Giving, Health Equity, Social Participation, Betacoronavirus/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Mutation/genetics, DNA, Viral/genetics, Health Systems/organization & administration, Health of the Disabled, COVID-19, Ghebreyesus, Tedros Adhanom, Covax, Thunberg, Greta
Coletiva de imprensa: anúncios do Governo 16/04/2021
Date:
16/04/2021
O Vice-Governador Rodrigo Garcia anunciou nesta sexta-feira (16) a atualização do Plano São Paulo, com início da fase de transição para todo Estado até o dia 2 de maio. Nas últimas semanas, os indicadores da saúde apresentaram uma redução progressiva, com queda nas internações e diminuição da ocupação hospitalar, o que permitiu o avanço para retomada gradativa e consciente das at...
See more details
Pandemics/statistics & numerical data, Local Health Systems/organization & administration, Quarantine/organization & administration, Social Isolation, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Epidemiological Monitoring, Commerce/standards, Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Viral Vaccines/immunology, Hypnotics and Sedatives/supply & distribution, Immunization Programs/organization & administration, COVID-19, Plano São Paulo, Garcia, Rodrigo , Instituto Butantan, Coronavac, Sinovac Biotech, Fase de transição , Kit intubação, Vacinômetro
WHO’s Science in 5 on COVID-19: vaccines, variants and mass gatherings
Date:
16/04/2021
How much protection does the current batch of COVID-19 vaccines provide us? Would you need a booster shot for new variants? What does science and evidence tell us about mass gatherings and the spread of COVID-19?
WHO’s Chief Scientist Dr Soumya Swaminathan explains in Science in 5 this week.
See more details
Betacoronavirus/genetics, Betacoronavirus/immunology, Pandemics/prevention & control, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Vaccine Potency, Viral Vaccines/immunology, Mutation/genetics, DNA, Viral/genetics, Health Communication, COVID-19
Media briefing on COVID-19 - 16/04/2021
Date:
16/04/2021
00:00:24
CL Hello and good day to wherever you are listening to us today. It's Friday 16th April and for us at least it's an unusual hour to have this press briefing so thank you anyway for joining us at this time. My name is Christian Lindmeier and I'm welcoming you to today's global COVID-19 press conference.
We have a few special guests today who I would like to briefly announce as w...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Immunization Programs/organization & administration, Betacoronavirus/immunology, Viral Vaccines/supply & distribution, Americas/epidemiology, Local Health Systems/organization & administration, Betacoronavirus/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Mutation/genetics, DNA, Viral/genetics, Access to Essential Medicines and Health Technologies, Health Equity, COVID-19, Ghebreyesus, Tedros Adhanom, Covax, Variante B1617
Butantan tem insumos para produzir mais doses da vacina
Date:
14/04/2021
Saiba mais em www.vacinaja.sp.gov.br
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Immunization Programs/organization & administration, Viral Vaccines/supply & distribution, Betacoronavirus/immunology, Coronavac, Plano São Paulo, COVID-19, Instituto Butantan, Sinovac Biotech
Ministério da Saúde procurou o Butantan para comprar mais doses
Date:
14/04/2021
Saiba mais em www.vacinaja.sp.gov.br
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Immunization Programs/organization & administration, Viral Vaccines/supply & distribution, Betacoronavirus/immunology, COVID-19, Plano São Paulo, Coronavac, Instituto Butantan, Sinovac Biotech
Vacinação do público de 63 e 64 anos
Date:
14/04/2021
Saiba mais em www.vacinaja.sp.gov.br
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Immunization Programs/organization & administration, Viral Vaccines/immunology, Aged, Betacoronavirus/immunology, COVID-19, Plano São Paulo, Coronavac, Instituto Butantan, Sinovac Biotech
